OpenLB
Open Library of Bioscience
Advanced Search
Obstetrics & gynecology science
Jan, 2025;68 (1): 30-42.

Decoding impact of human papillomavirus in gynecological oncology: a narrative review.

Md Safiullah Sarker, Mohammed Moshtaq Pervez
Author Information
  1. Md Safiullah Sarker: Virology Laboratory, Programme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka, Bangladesh.
  2. Mohammed Moshtaq Pervez: Hospital, Nutrition and Clinical Services Division, icddr,b, Dhaka, Bangladesh.
PMID: 39780583 DOI: 10.5468/ogs.24226

Abstract

Human papillomavirus (HPV) is a key factor in gynecological oncology. This narrative review investigates the complex connection between HPV and various gynecological cancers. For a comprehensive exploration, we examined the association between persistent HPV infection and cervical cancer and its global prevalence. Beyond the cervix, we navigated the linkages between HPV and other gynecological malignancies, shedding light on vulvar, vaginal, anal, and oropharyngeal cancers. The narrative extends to discuss the critical role of HPV vaccination in preventing these cancers and exploring challenges, controversies, and future perspectives in the field. As we have described the impact of HPV, this review underscores the significance of ongoing research and public health endeavors in shaping the trajectory of gynecological oncology.

Keywords

Cervical cancer Genital neoplasms Human papillomavirus infections

References

  1. Adv Drug Deliv Rev. 2021 Dec;179:113996 [PMID: 34634395]
  2. Lancet. 2004 Nov 13-19;364(9447):1757-65 [PMID: 15541448]
  3. PLoS One. 2022 Jun 9;17(6):e0269655 [PMID: 35679304]
  4. J Rural Health. 2019 Mar;35(2):208-215 [PMID: 29808500]
  5. J Infect Dis. 2001 Jan 1;183(1):8-15 [PMID: 11087198]
  6. J Pathol. 1999 Sep;189(1):12-9 [PMID: 10451482]
  7. Syst Rev. 2018 Mar 2;7(1):40 [PMID: 29499749]
  8. Oncol Lett. 2017 Apr;13(4):2495-2501 [PMID: 28454426]
  9. JAMA. 2000 Jan 5;283(1):81-6 [PMID: 10632284]
  10. Lancet Reg Health West Pac. 2023 Aug 01;39:100860 [PMID: 37576906]
  11. Euro Surveill. 2019 Feb;24(7): [PMID: 30782268]
  12. Vaccine. 2006 Aug 31;24 Suppl 3:S3/1-10 [PMID: 16949995]
  13. Oral Oncol. 2014 May;50(5):380-6 [PMID: 24461628]
  14. J Virol. 1991 Jan;65(1):292-8 [PMID: 1845889]
  15. Natl Med J India. 2023 Jan-Feb;36(1):17-21 [PMID: 37615134]
  16. Adv Dent Res. 2006 Apr 01;19(1):99-105 [PMID: 16672559]
  17. Klin Onkol. 2018 Spring;31(2):103-109 [PMID: 29708352]
  18. Infect Agent Cancer. 2016 Jan 15;11:2 [PMID: 26779280]
  19. Vaccine X. 2019 Aug 05;3:100037 [PMID: 31463471]
  20. Cancer. 2020 Jun 15;126(12):2859-2865 [PMID: 32212334]
  21. Med J Islam Repub Iran. 2021 May 22;35:65 [PMID: 34277502]
  22. J Oral Biol Craniofac Res. 2018 Jan-Apr;8(1):35-39 [PMID: 29556461]
  23. Vaccine. 2020 Feb 5;38(6):1302-1314 [PMID: 31870572]
  24. Cancer Med. 2023 Jul;12(13):14794-14805 [PMID: 37199394]
  25. BMC Cancer. 2023 Jul 20;23(1):683 [PMID: 37474918]
  26. Int Immunopharmacol. 2023 Apr;117:109882 [PMID: 36848790]
  27. Lancet Public Health. 2020 Sep;5(9):e484-e492 [PMID: 32707126]
  28. Sex Transm Dis. 2008 Mar;35(3):276-82 [PMID: 18091564]
  29. Nat Rev Immunol. 2004 Jan;4(1):46-54 [PMID: 14704767]
  30. Microb Pathog. 2022 Oct;171:105747 [PMID: 36064102]
  31. Gynecol Oncol. 2009 Sep;114(3):395-8 [PMID: 19501390]
  32. S Afr Med J. 2008 Apr;98(4):259-61 [PMID: 18637629]
  33. J Low Genit Tract Dis. 2018 Jul;22(3):225-230 [PMID: 29649025]
  34. Expert Rev Mol Diagn. 2008 Sep;8(5):599-605 [PMID: 18785808]
  35. J Cancer Educ. 2023 Feb;38(1):349-356 [PMID: 35022987]
  36. Cancer Prev Res (Phila). 2009 Oct;2(10):868-78 [PMID: 19789295]
  37. Tumour Biol. 2016 Apr;37(4):5295-303 [PMID: 26561467]
  38. Eur J Cancer. 2010 Nov;46(16):2973-85 [PMID: 20638840]
  39. J Adolesc Health. 2010 Apr;46(4 Suppl):S20-6 [PMID: 20307840]
  40. Curr Oncol. 2022 May 23;29(5):3780-3792 [PMID: 35621693]
  41. J Med Virol. 2013 Feb;85(2):288-94 [PMID: 23161344]
  42. PLoS One. 2014 Feb 05;9(2):e88323 [PMID: 24505474]
  43. J Cancer Res Clin Oncol. 2023 Aug;149(9):6489-6500 [PMID: 36780053]
  44. Talanta. 2024 Mar 1;269:125495 [PMID: 38043336]
  45. Cureus. 2020 Jun 4;12(6):e8434 [PMID: 32642349]
  46. Microorganisms. 2022 Sep 28;10(10): [PMID: 36296208]
  47. J Gynecol Oncol. 2020 Jan;31(1):e31 [PMID: 31789003]
  48. Exp Ther Med. 2020 Dec;20(6):186 [PMID: 33101476]
  49. NPJ Breast Cancer. 2022 Nov 9;8(1):121 [PMID: 36351947]
  50. Obstet Gynecol Sci. 2021 Sep;64(5):419-436 [PMID: 34384196]
  51. Vaccine. 2013 Dec 29;31 Suppl 5:F1-31 [PMID: 24331745]
  52. J Gen Intern Med. 2016 Nov;31(11):1360-1366 [PMID: 27184752]
  53. Hum Vaccin Immunother. 2023 Dec 31;19(1):2176640 [PMID: 36803510]
  54. J Adolesc Health. 2019 Jun;64(6):753-762 [PMID: 30777636]
  55. BMC Public Health. 2015 May 02;15:453 [PMID: 25934423]
  56. S Afr Med J. 2015 Jan 06;105(2):115-20 [PMID: 26242529]
  57. Obstet Gynecol Clin North Am. 2013 Jun;40(2):377-90 [PMID: 23732037]
  58. Med Clin North Am. 2020 Nov;104(6):1063-1078 [PMID: 33099451]
  59. Vaccine. 2012 Nov 20;30 Suppl 5:F1-11 [PMID: 23199951]
  60. Mem Inst Oswaldo Cruz. 2016 Nov;111(11):663-669 [PMID: 27783717]
  61. Viruses. 2023 Sep 07;15(9): [PMID: 37766295]
  62. Curr Opin Oncol. 2014 Jan;26(1):120-9 [PMID: 24248011]
  63. Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S19-23 [PMID: 17938013]
  64. Am J Obstet Gynecol. 1989 Apr;160(4):916-8 [PMID: 2540656]
  65. J Clin Microbiol. 2006 Apr;44(4):1310-7 [PMID: 16597856]
  66. Arch Gynecol Obstet. 2024 Apr;309(4):1681-1683 [PMID: 37310450]
  67. Vaccines (Basel). 2021 Jul 01;9(7): [PMID: 34358132]
  68. Cancer. 2007 Jun 25;111(3):145-53 [PMID: 17487850]
  69. Pediatr Infect Dis J. 2007 Sep;26(9):836-40 [PMID: 17721381]
  70. Acta Cytol. 2023;67(2):111-118 [PMID: 36646044]
  71. Pathogens. 2022 Dec 23;12(1): [PMID: 36678374]
  72. Front Biosci. 2007 Jan 01;12:246-64 [PMID: 17127297]
  73. Int Forum Allergy Rhinol. 2015 Aug;5(8):701-7 [PMID: 26077310]
  74. Prev Med. 2013 Nov;57(5):426-33 [PMID: 23402963]
  75. Curr Cancer Drug Targets. 2017;17(6):512-521 [PMID: 27993116]
  76. J Oncol. 2019 Oct 10;2019:3257939 [PMID: 31687023]
  77. Virol J. 2018 Feb 17;15(1):36 [PMID: 29454382]
  78. Am J Pathol. 2010 Nov;177(5):2169-75 [PMID: 20829441]
  79. J Virol. 1996 Nov;70(11):7549-60 [PMID: 8892874]
  80. Asian Pac J Cancer Prev. 2019 Oct 01;20(10):3181-3187 [PMID: 31653171]
  81. Gynecol Oncol. 2013 Feb;128(2):277-81 [PMID: 23200918]
  82. Cancer. 2023 Apr 15;129(8):1237-1252 [PMID: 36759972]
  83. Int J Environ Res Public Health. 2023 Feb 25;20(5): [PMID: 36901129]
  84. BMC Womens Health. 2023 Apr 28;23(1):209 [PMID: 37118735]
  85. Int J Gynecol Cancer. 2019 Oct;29(8):1317-1326 [PMID: 31455660]
  86. Vaccine. 2005 Mar 18;23(17-18):2388-94 [PMID: 15755633]
  87. BMC Med. 2023 Jul 27;21(1):274 [PMID: 37501128]
  88. BMC Public Health. 2023 Sep 1;23(1):1688 [PMID: 37658293]
  89. Prev Med. 2020 Jan;130:105902 [PMID: 31730943]
  90. Gastroenterol Res Pract. 2016;2016:7896716 [PMID: 26904111]
  91. PLoS One. 2016 Jan 14;11(1):e0146741 [PMID: 26766565]
Journal Article

Word Cloud

Created with Highcharts 10.0.0HPVgynecologicalpapillomavirusnarrativereviewcancersHumanoncologycancerimpactkeyfactorinvestigatescomplexconnectionvariouscomprehensiveexplorationexaminedassociationpersistentinfectioncervicalglobalprevalenceBeyondcervixnavigatedlinkagesmalignanciessheddinglightvulvarvaginalanaloropharyngealextendsdiscusscriticalrolevaccinationpreventingexploringchallengescontroversiesfutureperspectivesfielddescribedunderscoressignificanceongoingresearchpublichealthendeavorsshapingtrajectoryDecodinghumanoncology:CervicalGenitalneoplasmsinfections

Similar Articles

Cited By